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The transformation of normal prion protein into pathogenic variant in transmissible 
spongiform encephalopathy (TSE) is expedited by mutations. Three novel mutations 
V176G, E196A and I215V are associated with Creutzfeldt-Jakob disease (CJD) and 
Gerstmann–Sträussler–Scheinker syndrome (GSS).  These  mutations  are  novel  but  
have  yet  to  be  characterized.  The V176G mutation is exceptional as it showed GSS 
symptoms but resides in CJD prone segment of the prion structure. Using molecular 
dynamics simulations; comparative studies were performed between wild type and 
mutated  structures,  normal  and  elevated  temperature  and  neutral  and  acidic  pH to  
identify the dynamics in structural properties such as salt bridge, solvent accessibility,  
hydrogen bonds and hydrophobicity. Results indicated that overall effect of the three 
mutants is destabilization  of the native structure, increased hydrophobicity and 
electrostatic potential change and the gain of new hydrogen  bonds  but  are  only  
restricted  to  localized  effects  on  the  protein  such  as  increased fluctuation of the H1 
region, gain of new salt bridge in H3 and abolished salt bridges between H1 and H3 
which may be part of the oligomerisation pathways similar to GSS. The two CJD 
mutations, the E196A and I215V that possess a proximity effect on neighbouring regions 
of the mutated area. Simulations at elevated temperatures showed that the mutation 
caused the loss of hydrogen bonds between H3 and H2 with perturbations in the 
hydrophobic core that induces changes in the overall prion protein structure. In the 
V176G MD simulations, the mutation biggest effect is on the H1 of the protein where 
extreme conditions (elevated temperature and low pH) caused early denaturation 
compared to other segments of the prion protein.  These mutations also caused 
accelerated perturbation in the H1-S2 region and extended the existing S1 and S2. 
Simulations at different low pH regimes revealed that V176G, E196A and I215V 
mutated structures denatured earlier in pH 2.5 compared to pH 4.5 with increased 
fluctuations in H1, S2-H2 loop and H2-H3 loop. In conclusion, the apparent loss of salt 
bridges and hydrogen bond gains are the main reason for the conformational changes 














Transformasi  protein  prion  yang  normal  ke  varian  yang  patogenik  di  dalam  
penyakit berjangkit  seperti spongiform encephalopathy (TSE) disebabkan oleh 
mutasi.Tiga mutasi baru V176G, E196A dan I215V telah dikaitkan dengan penyakit 
Creutzfeldt-Jakob (CJD) dan sindrom Gerstmann-Sträussler-Scheinker  (GSS).  Ketiga-
tiga mutasi  ini  adalah  unik  dan  masih  belum  di perincikan setakat ini. Mutasi V176G 
adalah luar biasa kerana ia menunjukkan tanda-tanda penyakit GSS tetapi kedudukan  
mutasi berada di dalam bahagian protin yang menyebabkan penyakit CJD. Menggunakan  
simulasi  molekul  dinamik;  kajian  perbandingan  telah  dijalankan  antara  struktur 
normal dan struktur bermutasi, pada suhu normal dan tinggi dan pada pH neutral dan 
berasid untuk mengenal pasti perubahan dinamik pada sifat-sifat struktur  seperti 
jambatan garam, akses pelarut, ikatan hidrogen dan sifat  kehidrofobikan.Keputusan  
menunjukkan  bahawa  kesan  tiga  mutan tersebut  adalah  ketidakstabilan  struktur  
asal,  meningkat  kehidrofobikan  dan  perubahan  potensi elektrostatik  dan  
pertambahan  ikatan  hidrogen  baru. Walau  bagaimanapun,  mutasi  ini tidak 
menyebabkan perubahan yang ketara kepada struktur secara keseluruhan.Ketidakstabilan  
yang disebabkan oleh mutasi ini mungkin telah menyebabkan kesan setempat pada 
struktur protein seperti peningkatan  gerakan  dinamik  di  bahagian  H1, pertambahan  
jambatan  garam  baru  di  H3  dan pemansuhan jambatan garam antara H1 dan H3 yang 
mungkin boleh menjadi sebahagian daripada laluan penwujudan oligomer yang 
menentukan profil patologi yang unik pada penyakit GSS.  Kedua- dua mutasi, E196A 
dan I215V telah menghasilkan manifestasi simtom klinikal yang serupa dengan CJD 
telah terbukti mempunyai kesan setempat di sekita jujukan asid amino berdekatan 
kawasan mutasi. Simulasi pada suhu tinggi menunjukkan bahawa mutasi telah 
menyebabkan kehilangan ikatan hidrogen antara H3 dan H2 beserta gangguan di dalam 
teras hidrofobik yang mendorong perubahan di dalam struktur protein prion secara 
keseluruhan.  Sebahagian dari S2-H2 dan H2-H3 telah diketahui sebagai sangat mudah 
dipengaruhi oleh  perubahan asid amino, oleh itu mutasi ini telah menyebabkan kesan 
yang besar ke atas struktur.  Jambatan garam baru juga dibentuk di dalam teras 
hidrofobik.  Dalam simulasi V176G, kesan mutasi yang paling besar adalah pada helik 
H1 di mana keadaan yang melampau (suhu tinggi dan pH rendah) telah menyebabkan 
penyahaslian struktur lebih awal berbanding segmen lain protein tersebut. Mutasi  ini  
juga  menyebabkan  gangguan dipermudahkan di bahagian H1-S2 dan memanjangan 
jujukan S1 dan S2 yang sedia ada.  Simulasi pada keadaan pH yang rendah menunjukkan 
bahawa V176G, E196A dan I215V akan didenaturkan lebih mudah pada pH 2.5 
berbanding pH 4.5.  Ini akan meningkatkan dinamik H1, bahagian S2-H2 dan  gelung  
H2-H3.Kesimpulannya,kehilangan ketara  jambatan  garam  dan  perubahan  ikatan 
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Prions diseases are diseases that are caused by proteinacious infectious 
agent (Prusiner, 1998).  The term ―prion‖ was originally coined to denote the 
causative agent for a group of progressive neurodegenerative disorders called 
transmissible spongiform encephalopathies (TSEs), such as Creutzfeldt-Jakob 
disease (CJD) in humans, bovine spongiform encephalopathy (BSE) in cattle, 
chronic wasting disease (CWD) in deer and elk, and scrapie in sheep (Colby 
and Prusiner, 2011).  The majority of human prion diseases are sporadic with 
undetermined origins while 15% are caused by heritable mutations; the 
(Gerstmann-Sträussler-Scheinker syndrome (GSS), fatal familial insomnia 
(FFI) and familial CJD).  Prion diseases are unique as they are infectious and 
can be caused by exposure to contaminated material, such as prion-infected 
beef.  Examples of infectious prion diseases include kuru, variant CJD and 
iatrogenic CJD (iCJD).  Pathological characteristics include relatively long 
incubation periods, extreme vacuolation in specific regions of the brains and 
general neuronal degeneration.  So far, all prion associated diseases are fatal 
and no cure has been found. 
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Prion studies have utilized various techniques, in-vitro, and in-vivo but 
most importantly, it is studied post-mortem.  The delayed onset of the disease 
and invasive nature of tests have forced researcher to adopt techniques such as 
molecular dynamics (MD) simulations.  MD simulation studies are appropriate 
as the lack of covalent modification in PrPC to PrPSc conversion.  The 
conformational rearrangement between the two structures provides a chance to 
study purely from the structural dynamics point of view.  The transition from 
PrPC to PrPSc cannot be studied experimentally, especially the unfolding 
transition between these two states.  The hydrophobic nature of PrPSc also 
prevents effective and correct structure determination by X-ray 
crystallography, or even using NMR spectroscopy.  Hence, MD simulation 
techniques have become a viable method for studying PrPC to PrPSc 
conversion.  Amino acid changes that form the body of evidence of 
destabilizing mutations that predisposes the organism to prion diseases also 




Molecular dynamics have utilized extreme condition to mainly study 
the effect of prion structural stabilities.  Two of the main strategies used to 
achieve structural changes are thermal and low pH denaturation.  In thermal 
denaturation, wild type and mutant PrP are simulated at elevated temperature 
of 500 K (El-Bastawissy et al., 2001, Sekijima et al., 2003a, Sekijima et al., 
2003d).  By elevating the temperature, the protein unfolding can be accelerated 
without changing the pathway of unfolding and this enables the determination 
of the unfolding pathway at minimal computational expense (Day et al., 2002).  
In low pH induced denaturation, experimental evidence have showed that 
acidic pH is capable to induce PrPC to PrPSc (Alonso et al., 2002, Alonso et 
al., 2001, DeMarco and Daggett, 2004, DeMarco and Daggett, 2007, Gu  et al., 
2003, Kuwata et al., 2003, Langella et al., 2004, Sekijima et al., 2003a, 
Sekijima et al., 2003d).  The hypothesis of using low pH conditions in MD 
simulations is that the protein will be stable at the normal pH but will undergo 
a conformational change at the lower pH due to the altered protonated states.  
This will disrupt local interactions enabling the peptide to adopt conformations 
3 
 
that are unlikely at neutral pH.  The decreased structural stability at acidic pH 
resulted in increased flexibility and dynamics, which might provide a starting 
point for the processes that ultimately, leads to conformational transformation.  
In these two extreme condition MD simulations, the β sheets have been 
implicated as the changes have included elongation of existing β sheets and 
formation of β-sheets in the highly disordered region of the N terminus of PrP 
(Alonso et al., 2002, Alonso et al., 2001, DeMarco and Daggett, 2004).  This 
occurrence may play a seeding role during the initial stages of PrP to PrPSc 





1.2 Problem Statement 
 
 
While the Human familial prion diseases related to PrP originated from 40 
points mutations and most of the mutations occur in the protein globular 
domain (Guo et al., 2012a, Rossetti et al., 2011).  The role in protein 
misfolding which is central to prion disease development has not been 
explored in full detail these mutations are responsible for spontaneous 
generation of PrPSc in the brain (Prusiner, 1994).  The mutation‘s effect of the 
dynamic instability in PrPC enhances the misfolding kinetics of PrP WILD 
TYPE (Liemann and Glockshuber, 1999, Swietnicki et al., 1998) and the 
stability of partially folded intermediate species such as PrPSc precursors 
(Apetri et al., 2004, Horiuchi and Caughey, 1999, Rossetti et al., 2011, 
Surewicz et al., 2006).  The analysis of mutations carrying PrP provides 
significant insights into factors that increase the likelihood of misfolding and 
induces different types of spontaneous prion diseases even in the absence of 
infection from exogenous sources (Biasini et al., 2008, Jeffrey et al., 2009). 
The aim in this study was to test in vitro, three novel mutations (V176G, 
E196A and I215V) were studied using molecular dynamics simulations.  
These mutations are only recently reported and are unusual in their co-
occurrence in single patient or within the same family. The (V176G) is a novel 
4 
 
PRNP mutation associated with a neuropathologically condition identified in a 
single patient.  Post mortem analysis revealed unique neuropathological profile 
consisting of high amyloid plaque encumbers, neurofibrillary degeneration and 
the brain spongiform alterations similar to Gerstmann-Sträussler-Scheinker 
(GSS).  However, the V176G is located on the area known for CJD mutations 
(Rossetti et al., 2011).  The mutations E196A and I215V are novel PRNP 
mutations that has been shown to possess distinct clinical phenotypes and 
overlapping of clinicopathological features related with CJD.  The mutations 
V176G, E196A and I215V as well as their wild type (WILD TYPE) are 
simulated to study their dynamics and physicochemical properties such as salt 
bridge, solvent accessibility and hydrophobicity. This study will improve 
current understanding of the misfolding process and the factors that influence 





1.3 Objectives of the Research  
 
 
1. To study the effect of Creutzfeldt-Jakob disease mutation E196A, I215V 
on prion protein. 
2. To study of effect of V176G Gerstmann-Sträussler-Scheinker mutation 
that possess Creutzfeldt-Jakob disease symptom. 
3. To investigate conformational changes of mutant protein using molecular 
dynamics. 












1.4 Scope of the Research  
 
 
The scope of the study is purely bioinformatics and computational 
analysis where all the data are derived from primary data bases and analysed 





5.2  Future Works 
 
 
Currently, there are as many as 40 different mutation associated with 
prion diseases.  The existing limitations such as lack of experimentally 
determined structure, post-mortem detection, sporadic onset and computing 
processing have limited majority of the work to be theoretical in nature.   
Future work should focus on testing the aetiology of the V176G, E196A and 
I215V mutations and looking to discover the separate symptom pathology 
form a molecular level using in-vitro method.  However, this requires 
extensive animal model work and genetic screening to detect presence of 
mutated prion.  The long term commitment of resources would limit the focus 
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